Literature DB >> 4003792

The effect of increasing age on thiopental disposition and anesthetic requirement.

T D Homer, D R Stanski.   

Abstract

The dose of thiopental required to induce anesthesia in adults decreases with age. The pharmacokinetic and pharmacodynamic properties of thiopental were studied in two groups of surgical patients to determine the mechanism of this decrease. In one group (29 patients 19-88 yr of age), thiopental was infused at a rate of 75-150 mg/min until the electroencephalogram (EEG) demonstrated early burst suppression (phase III). Arterial blood samples were obtained frequently during and after the infusion to measure serum thiopental concentrations, and power spectral analysis was used to calculate the spectral edge (Hz), defined as the frequency below which 95% of the EEG power is located. Pharmacodynamic modeling was used to relate the serum thiopental concentrations to the spectral edge in order to estimate the individual patient's brain sensitivity to thiopental. In a second group (28 patients 24-88 yr of age), pharmacokinetics were determined after a bolus or rapid infusion of thiopental. Arterial blood samples were obtained frequently to characterize the initial distribution phases, sampling continued for 24-48 h to characterize elimination processes. The dose of thiopental required to achieve early burst suppression on the electroencephalogram (EEG) decreased linearly and significantly with age. Pharmacodynamic modeling also demonstrated that brain sensitivity to thiopental does not change with age. The age-related decrease of the thiopental dose requirement is due to a change in the initial distribution of the drug. That is, the initial distribution volume (central compartment, or V1) of thiopental decreases exponentially with age. This smaller initial distribution volume in the elderly results in higher serum levels after a given dose of thiopental.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4003792     DOI: 10.1097/00000542-198506000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  29 in total

Review 1.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Comparison between hemodynamic effects of propofol and thiopental during general anesthesia induction with remifentanil infusion: a double-blind, age-stratified, randomized study.

Authors:  Hideki Hino; Tadashi Matsuura; Yuki Kihara; Shogo Tsujikawa; Takashi Mori; Kiyonobu Nishikawa
Journal:  J Anesth       Date:  2019-06-21       Impact factor: 2.078

4.  Estimating the rate of thiopental blood-brain equilibration using pseudo steady state serum concentrations.

Authors:  P O Maitre; M Bührer; S L Shafer; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

5.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

6.  Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis.

Authors:  J W Mandema; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

Review 7.  Anaesthesia in the elderly. Special considerations.

Authors:  A G Jones; J M Hunter
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 8.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

9.  First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial.

Authors:  Ann E Rigby-Jones; J Robert Sneyd; Peter Vijn; Patrick Boen; Maurice Cross
Journal:  BMC Anesthesiol       Date:  2010-06-29       Impact factor: 2.217

Review 10.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.